RECONFIGURABLE BIOPROCESSING SYSTEM
    185.
    发明公开

    公开(公告)号:US20240182834A1

    公开(公告)日:2024-06-06

    申请号:US18553821

    申请日:2022-04-25

    Abstract: The present disclosure relates to a reconfigurable bioprocessing system (80) operable to perform a predetermined set of bioprocessing operations within the bioprocessing system (80), the bioprocessing system (80) comprising: a base unit (60) comprising a plurality of valve actuators, wherein at least one of the plurality of valve actuators is configured to releasably engage with a membrane valve cassette (200, 300, 400) that is removably attachable to the base unit (60), and wherein the at least one of the plurality of valve actuators is actuatable to regulate fluid flow through the membrane valve cassette (200, 300, 400); and a control system (20) operable to selectively actuate respective ones of the plurality of valve actuators to provide a valve configuration within the membrane valve cassette (200, 300, 400) to enable the base unit (60) and the membrane valve cassette (200, 300, 400) together to perform one of the predetermined set of bioprocessing operations.

    Method for Cell Line Development
    187.
    发明公开

    公开(公告)号:US20240043879A1

    公开(公告)日:2024-02-08

    申请号:US18467658

    申请日:2023-09-14

    CPC classification number: C12N15/907 C12P21/00 C07K16/00 C12N2510/02

    Abstract: The present invention relates to an improved method for cell line development (CLD) which is generally applicable to production of any therapeutic protein that can be produced using mammalian Cell lines and in particular Chinese Hamster Ovary (CHO) cells.
    The method combines site-directed integration (SDI), expression construct components improving the post-transcriptional processing of the gene of interest (GOI) and the introduction of a onetime pre-CLD host cell line selection workflow to generate a production competent cell line that can then be used in multiple CLD efforts using SDI from that point on.

Patent Agency Ranking